Development and validation of oral chemotherapy self-management scale
- PDF / 768,962 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 2 Downloads / 213 Views
RESEARCH ARTICLE
Open Access
Development and validation of oral chemotherapy self-management scale Qi Peng and Wanying Wu*
Abstract Background: With the increase of oral chemotherapy drugs, patients receiving cancer treatment prefer oral chemotherapy versus intravenous, given equal efficacy and toxicity. However, they need to take an active part in their care, which is vital with home-based oral therapy, therefore the self-management is important for patients with oral chemotherapy. Unfortunately, the development of self-management assessment tools for oral chemotherapy still lags behind. Methods: The OCSMS item pool was formulated based on literature review and semi-structured interviews, An initial scale containing 5 dimensions and 38 items was constructed through research seminar, Delphi survey and pilot testing. To assess the validity and reliability, We recruited 261 patients from cancer hospital in China. Results: A 36-item scale was developed with five dimensions identified through factor analysis: daily life management, symptom management, medication management, emotional cognitive management and social support. Cronbach’s coefficient Alpha, split-half coefficient, test-retest reliability and S-CVI/UA scores were 0.929, 0.773, 0.966 and 0.833, respectively, indicating that OCSMS has good reliability and validity. Conclusions: The OCSMS is a valid, reliable measurement method of the self-management ability of patients with oral chemotherapy. The OCSMS shows potential as a tool to ensure the safety of patients with cancer. The OCSMS may help evaluate the effectiveness of interventions to improve the self-management ability of patients. Keywords: Cancer, Oral chemotherapy, Self-management, Validation
Background Chemotherapy is one of the most important treatments for cancer, and the route of chemotherapy administration is developing continuously. With the spread of oral chemotherapy agents over the last 15 years, people are choosing oral chemotherapy because it is safe, economical and helps prevent venepuncture [1–3]. Patients are likely to choose oral chemotherapy than intravenous chemotherapy even with their same efficacy and toxicity [4]. With oral anticancer agents becoming widely common, a critical shift has occurred from clinic-based * Correspondence: [email protected] Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, East Banshan Road, Gongshu District, Hangzhou, Zhejiang, People’s Republic of China 310022
healthcare provider-administered management to homebased self-administered management [5]. However, it also brings new challenges. For example, patients at home can’t recognize the undesirable side effects, such as nausea and vomiting [4, 6]. Hence, the patient’s selfmanagement ability is very important. Self-management was proposed by Corbin and Straus for chronic disease [7] and has been defined as managing symptoms, treatments, lifestyle alterations and psychosocial consequence
Data Loading...
